摘要
Here we describe an NMR and X-ray crystallography-based characterisation of the mechanism by which a new class of macrocyclic peptidomimetic aldehyde inhibits alpha-chymotrypsin. In particular, a C-13-labelled analogue of the inhibitor was prepared and used in NMR experiments to confirm formation of a hemiacetal intermediate on binding with alpha-chymotrypsin. Analysis of an X-ray crystallographic structure in complex with alpha-chymotrypsin reveals that the backbone adopts a stable beta-strand conformation as per its design. Binding is further stabilised by interaction with the oxyanion hole near the S-1 subsite and multiple hydrogen bonds.
- 出版日期2016